Insulet: Omnipod 5 Driving Revenue – But Expenses Elevated
nambitomo Insulet (NASDAQ:PODD), a company that develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes, has a big winner with its Omnipod 5 automated insulin delivery system, which is exceeding revenue estimates, […]
